M&A Deal Summary

Nucleus Biologics Acquires Primorigen Biosciences

On August 6, 2019, Nucleus Biologics acquired life science company Primorigen Biosciences

Acquisition Highlights
  • This is Nucleus Biologics’ 1st transaction in the Life Science sector.
  • This is Nucleus Biologics’ 1st transaction in the United States.
  • This is Nucleus Biologics’ 1st transaction in Wisconsin.

M&A Deal Summary
Date 2019-08-06
Target Primorigen Biosciences
Sector Life Science
Buyer(s) Nucleus Biologics
Deal Type Add-on Acquisition

Target

Primorigen Biosciences

Madison, Wisconsin, United States
Primorigen Biosciences, Inc. is a biotechnology company is a research and manufacturing company that has a proprietary process for producing high-quality full length recombinant human proteins. Primorigen Biosciences is based in Madison, Wisconsin.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Nucleus Biologics

San Diego, California, United States
Category Company
Sector Life Science
DESCRIPTION

Nucleus Biologics is a biotechnology company and a global provider of media and supplements for the cell and gene therapy space. Nucleus Biologics is based in San Diego, California.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Wisconsin) 1 of 1
Country (United States) 1 of 1
Year (2019) 1 of 1
Mergr

Product

Company

Legal